ARTICLE | Clinical News
Telcyta: Phase III data
November 3, 2008 8:00 AM UTC
Data from the intent-to-treat (ITT) population of 125 patients with platinum-refractory or resistant ovarian cancer in the open-label, international Phase III ASSIST-5 trial, showed that Telcyta plus ...